Oruka Therapeutics, Inc.
Q1 2026 13F Holders
Symbol
ORKA
CUSIP
687604108
Type
Equity
Class
COM
Num filings
190
Total reported value, excl. options
$2.61 B
Compare 2026 Q1 to
2026 Q3
2026 Q2
2025 Q4
2025 Q3
2025 Q2
2025 Q1
2024 Q4
2024 Q3
Manager
Report Date
Value ($000)
Shares
Option Type